Waters Corporation Cash per Share

Cash per Share of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash per Share growth rates and interactive chart.


Highlights and Quick Summary

  • Cash per Share for the quarter ending December 30, 2020 was 7.14 (a 11.44% increase compared to previous quarter)
  • Year-over-year quarterly Cash per Share increased by 12.76%
  • Annual Cash per Share for 2020 was 7.14 (a 43.15% increase from previous year)
  • Annual Cash per Share for 2019 was 4.99 (a -77.88% decrease from previous year)
  • Annual Cash per Share for 2018 was 22.54 (a -47.01% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash per Share of Waters Corporation

Most recent Cash per Shareof WAT including historical data for past 10 years.

Interactive Chart of Cash per Share of Waters Corporation

Waters Corporation Cash per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 7.14 6.4 5.74 6.33 7.14
2019 4.99 6.11 9.8 16.28 4.99
2018 22.54 27.22 28.89 32.35 22.54
2017 42.53 40.83 39.08 37.05 42.53
2016 34.82 33.63 32.17 30.82 34.82
2015 29.14 28.17 26.75 25.4 29.14
2014 24.37 23.26 22.7 21.81 24.37
2013 21.11 19.95 19.3 18.48 21.11
2012 17.52 16.57 15.76 15.21 17.52
2011 14.11 13.17 12.24 11.34 14.11
2010 10.24 9.13 8.15 10.24

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.